UnknownNot applicableNCT02028416

Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Blood Disease Center, Pakistan
Principal Investigator
TAHIR S SHAMSI, MBBS,FRCPath
NATIONAL INSTITUTE OF BLOOD DISEASES AND BONE MARROW TRANSPLANTATION
Intervention
ATG-fresenius(drug)
Enrollment
60 enrolled
Eligibility
2-65 years · All sexes
Timeline
20132017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02028416 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia

← Back to all trials